Vireo Growth (VREOF) Receivables (2020 - 2026)
Vireo Growth (VREOF) posted Receivables of $2.0 million for Q1 2026, down 84.25% sequentially from $12.7 million in Q4 2025, and down 17.51% YoY from $2.4 million in Q1 2025.
Vireo Growth (VREOF) Receivables (2020 - 2026) Analysis & Trends
Vireo Growth has reported Receivables for 7 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Receivables fell 17.51% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 17.51% YoY) and the FY2025 annual result came in at $12.7 million, up 317.1% from the prior year.
- Receivables slipped to $2.0 million in Q1 2026 per VREOF's latest filing, from $12.7 million in the prior quarter.
- Over five years, Receivables peaked at $12.7 million in Q4 2025 and troughed at $829877.0 in Q4 2023.
- A 5-year average of $4.4 million and a median of $3.6 million in 2023 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 638.3% in 2025, down 87.48% in 2025.
- Over 5 years, Receivables stood at $1.4 million in 2022, then tumbled by 41.6% to $829877.0 in 2023, then surged by 107.28% to $1.7 million in 2024, then surged by 638.3% to $12.7 million in 2025, then sank by 84.25% to $2.0 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $2.0 million, $12.7 million, and $988641.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | 8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 988,641.00 |
| Jun 30, 2025 | 9.14 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Mar 31, 2024 | 5.13 Mn |
| Dec 31, 2023 | 829,877.00 |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 859,103.00 |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 233,526.00 |
| Sep 30, 2021 | 975,205.00 |
| Jun 30, 2021 | 2.31 Mn |